Register for CDMO Webinar – February 10 2022

In this webinar, you will learn about:

• Top reasons to outsource to a CDMO
• Overcoming hurdles with a CDMO partnership
• What early-stage biotechs should look for in a CDMO

Detailed description: 

A recent survey commissioned by

 across more than 50 small, mid-sized and large biopharmaceutical companies worldwide, shed light on the key reasons why biotechs outsource their early biologic development and manufacturing to a CDMO.

In this 20-minute panel discussion, members of

End-to-End Solutions team, part of the BioReliance^® portfolio, will offer their perspectives on what we heard from respondents. We will discuss major hurdles biotechs mentioned and how a customer-centric CDMO partnership can help overcome these, dismissing the idea of one-size-fits-all.

An on-demand version of this webinar will be available after February 10 using the same link. Register now and access the webinar at your convenience.